| |
Moderators
08.00
|
|
|
M. Bosiers, R. Hassen-Khodja
Miscellanous
|
| |
08.00 |
|
|
Should we stop Clopidrogrel before open vascular surgery?, C. Saadeh  |
| |
08.10 |
|
|
Myocardial infarction following vascular surgery: why should we take it seriousl?
P. Schneider |
| |
08.20 |
|
|
Carotid |
| |
08.20 |
|
|
Which asymptomatic stenosis are at risk of stroke?, S. Kakkos |
| |
08.30 |
|
|
Watershed infarct: do they influence the results of carotid surgery?, E. Jean-Baptiste |
| |
08.40 |
|
|
Discussion |
| |
08.50 |
|
|
Controversy: CEA and CAS |
| |
08.50 |
|
|
CEA is Superior to CAS: an EBM conclusion, A. Stella |
| |
09.00 |
|
|
CEA is not superior to CAS: we simply do not have the answer yet, A. W. Hallyday |
| |
09.10
09.10
09.20
|
|
|
Can we improve the results of CAS?
What the recent data of CAS versus CEA tell us, S. Macdonald
Discussion
|
| |
09.30
09.30 |
|
|
CAS: what factors should be taken into account
High volume versus low volume centers, P. Cao |
| |
09.40 |
|
|
Early treatment after onset of symptoms, G. Fraedrich |
| |
09.50
10.00 |
|
|
Proximal protection devices, A. Cremonesi
Discussion |
| |
|
|
|
|
| |
10.10 |
|
|
Break in the exhibition hall |
| |
|
|
|
|
| |
10.40 |
|
|
More on short or no neck aneurysms |
| |
Moderators
|
|
|
F. J. Veith, E. Verhoeven, M. Malina, A. Khayati
|
| |
10.40
10.50
11.00
11.10
|
|
|
Controversy: Open repair or endo repair
FEVAR is the current gold standard, I. Loftus
Open surgery is the only proven procedure, J-B. Ricco
Which patients should not be treated endo, X. Chaufour
Discussion
|
| |
11.00
11.15
11.45
12.00
|
|
|
ePosters competition
Jury members P. Desgranges & R. Hassen Khodja
Clinical cases presented by J-P. Becquemin
discussed by P. Cao, N. Cheshire, L. Chiche, H-H. Eckstein, M. Malina, F. J. Veith
Honorary guest lecture: the evolution of endovascular therapy and its impact on the future, E. Diethrich
Industry symposia
   
|
| |
|
|
|
|
| |
13.00 |
|
|
Lunch in the exhibition hall |
| |
|
|
|
|
| |
Moderators |
|
|
J. Brunkwall, E. Ducasse, P. Kasprzak |
| |
|
|
|
New technology for short and no neck aneurysm |
| |
14.00 |
|
|
Urgent need: how to customize a fenestrated graft in 2 hours, F. Cochennec |
| |
14.10 |
|
|
Off the shelf stent graft for TAAA, S. Haulon |
| |
14.20 |
|
|
The Ventana device: one device fits all, J-P. Becquemin |
| |
14.30 |
|
|
The Anaconda device, P. Bungay |
| |
14.40 |
|
|
Multilayer flow: too good to be true? Principles, E. Diethrich |
| |
14.50 |
|
|
Multilayer flow: too good to be true? Clinical results, C. Vaislic |
| |
15.00 |
|
|
Fenestrated and branched graft around the globe: what are the pieces of evidence |
| |
15.00 |
|
|
GB the BESET registry, R. S. Vallabhaneni |
| |
15.10 |
|
|
France: The Windows 1, 2 and 3 studies, J-P. Becquemin |
| |
15.20 |
|
|
USA: 10 years experience of the Cleveland clinic: are we up to the goal, T. Mastracci |
| |
15.30 |
|
|
Fate of visceral stents in F and B stent grafts, P. Kasprzak |
| |
15.40 |
|
|
Discussion |
| |
15.50 |
|
|
AAA rupture the old enemy is still there: is Endo the wrong choice? |
| |
15.50 |
|
|
Disappointment from the Ajax trial: no benefit from rEVAR, A. C. Vahl |
| |
16.00 |
|
|
Results worse than expected what is the problem, D. Mayer |
| |
16.10 |
|
|
Rupture with no neck is not a contra indication for EVAR, M. Malina |
| |
16.20 |
|
|
Discussion |
| |
16.30
16.30
16.40
16.50 |
|
|
Controversy: ruptured AAA treatment
Fix it rapidly by an open repair: it is the safest way, J. Schmidli
EVAR is better than open repair: do not believe figures, F. J. Veith
Discussion |
| |
17.00 |
|
|
Adjournment |
